Mirion Technologies stock reacts to renewed attention

Recent coverage highlighting Mirion Technologies (MIR) for its revenue growth, improved operating efficiency, and market share gains has brought the stock back into focus for investors watching business services companies.

Even with the recent 4.20% 1 day share price gain to US$18.35, Mirion’s 30 day share price return is still down 5.07%. The 3 year total shareholder return of 135.26% hints at a stock where long term momentum has contrasted with more cautious recent trading.

If renewed interest in Mirion has you thinking about where else growth and technology intersect, it could be a good time to look at 88 nuclear energy infrastructure stocks

With the stock up over the past day but still down over the past month and year, and with analyst targets sitting above the current US$18.35 price, the key question is whether Mirion is still undervalued or if the market is already accounting for its future growth potential.

Most Popular Narrative: 35% Undervalued

At $18.35, the most followed narrative around Mirion points to a fair value of $28.10, which implies a sizable valuation gap based on analyst-style forecasts.

The accelerating global shift toward expanded nuclear power generation, coupled with rising capital budgets for modernization, life extensions, and increased capacity of the existing reactor fleet, is likely to drive sustained double-digit organic revenue growth and expand Mirion's higher-margin installed base business in coming years.

Strong momentum in advanced nuclear projects, including utility-scale new builds and rapid activity in the small modular reactor (SMR) market, has materially broadened Mirion's pipeline of large, multi-year opportunities, creating potential for significant step-changes in future order intake, backlog, and top-line revenue.

Curious what kind of revenue path, margin reset, and future earnings multiple are baked into that $28.10 fair value? The narrative leans on aggressive profit compounding, a richer profitability profile, and a punchy future valuation benchmark that looks very different to broad sector norms.

Result: Fair Value of $28.10 (UNDERVALUED)

However, investors still need to weigh the heavy reliance on the nuclear sector, as well as the execution risks around acquisitions like Certrec, either of which could challenge this upside case.

Another Angle On Valuation

The analyst narrative refers to a fair value of $28.10, but the SWS DCF model presents a different perspective. In that model, Mirion at $18.35 is trading above an estimated future cash flow value of $15.09. This suggests the stock may be overvalued based on that measure and leaves you to decide which valuation approach seems more realistic.

Next Steps

With such a mixed picture on valuation and future potential, sentiment on Mirion is understandably split. It therefore makes sense to review the underlying data yourself and decide quickly where you stand based on the company's 3 key rewards and 3 important warning signs.

Looking for more investment ideas?

If Mirion is on your radar, do not stop there. Broader opportunities across sectors could fit your goals just as well, or even better.

• Target potential mispricings by scanning 49 high quality undervalued stocks that combine solid fundamentals with room for the market to reassess them.
• Build a steadier income foundation by reviewing 10 dividend fortresses that aim to pair higher yields with more resilient payouts.
• Sleep easier at night by focusing on 66 resilient stocks with low risk scores that score well on financial strength and risk controls.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.